Often the details are the difficulty
The basic requirements for computerized systems differ only slightly in the specially regulated areas. This can lead to problems during inspections.
For example, some countries in the GLP area require that the source code of the software must be available in the test facility or can be provided at short notice. This requirement does not exist in the GMP-regulated environment.
In the GCP, GMP, and GDP area, the “Good Automated Manufacturing Practice 5” (GAMP® 5) 2nd Edition guidelines of the International Society for Pharmaceutical Engineering (ISPE®) have become established as a guideline for practical implementation.
The 2nd edition clearly emphasizes the validation of medical devices and their business and production processes, including their computerized systems. This brings new challenges for manufacturers of medical devices, as the entire documentation is expanded to include validation plans, specifications, and validation reports along with the previous verification. We support you in this process of finding the gaps and filling these with the necessary documentation.
In the GLP area, Germany is guided by OECD Guideline No. 17 and Annex 3: Inspection of data processing (DV) systems of the Manual for GLP Inspections.
Depending on the complexity and criticality of the system, individual tests that are typically part of an overall validation can be assessed on a risk basis and omitted.